These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27498728)

  • 1. [Rapid improvement of hyperammonemic encephalopathy by bortezomib treatment in IgD-type multiple myeloma].
    Esaki M; Ishii K; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Satake A; Ito T; Nomura S
    Rinsho Ketsueki; 2016 Jul; 57(7):854-8. PubMed ID: 27498728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
    Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
    Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgD lambda multiple myeloma causing hyperammonaemia with possibly reduced ammonium excretion.
    Isse N; Nakahara K; Sasai R
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35858739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive Plasmablastic Myeloma With Extramedullary Cord Compression and Hyperammonemic Encephalopathy: Case Report and Literature Review.
    Dah K; Lavezo JL; Dihowm F
    Anticancer Res; 2021 Nov; 41(11):5839-5845. PubMed ID: 34732460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.
    Pham A; Reagan JL; Castillo JJ
    Leuk Res; 2013 Oct; 37(10):1229-32. PubMed ID: 23932549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemic encephalopathy in multiple myeloma.
    Jones FM; Bokhari SW
    Ann Hematol; 2014 Aug; 93(8):1431-2. PubMed ID: 24292538
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report.
    Verma K; Zhang T; Mueller D; Li J; Sanchorawala V; Staron A
    Diagn Pathol; 2023 Jan; 18(1):1. PubMed ID: 36597112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma.
    Kishi S; Obata F; Miki H; Matsuura M; Nishimura K; Tamaki M; Kishi F; Murakami T; Abe H; Nagai K; Abe M; Doi T
    Intern Med; 2018 Dec; 57(24):3597-3602. PubMed ID: 30101939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
    Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
    Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma].
    Ikeda H; Hayashi T; Nojima M; Yasui H; Ikeda Y; Ishida T; Adachi M; Imai K
    Rinsho Ketsueki; 2005 Apr; 46(4):269-73. PubMed ID: 16444959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Massive ascites as an initial sign, plasmacytoma of the cervical supine, and hyperammonemic consciousness disturbance in a patient with biclonal type multiple myeloma].
    Ohmoto A; Kohno M; Yasukawa K; Matsuyama R
    Rinsho Ketsueki; 1996 Apr; 37(4):346-51. PubMed ID: 8847807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
    Grannis CH; Dewan VN; Wang RC
    Retin Cases Brief Rep; 2014; 8(4):348-51. PubMed ID: 25372546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma presenting as hyperammonemic encephalopathy.
    Bénet B; Alexandra JF; Andrieu V; Sedel F; Ajzenberg N; Papo T
    J Am Geriatr Soc; 2010 Aug; 58(8):1620-2. PubMed ID: 20942894
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperammonemic encephalopathy as the presenting feature of multiple myeloma].
    Fernández-Álvarez R; González-García E; Fernández-Álvarez C
    Med Clin (Barc); 2016 Nov; 147(10):472-473. PubMed ID: 27567337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Maintenance hemodialysis in IgD- lambda -type multiple myeloma associated with severe renal failure].
    Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):177-81. PubMed ID: 8139151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperammonemic encephalopathy in multiple myeloma].
    Oestmann A; Aujesky D
    Dtsch Med Wochenschr; 2014 Jul; 139(30):1518-20. PubMed ID: 25072861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary plasma cell leukemia (IgD-lambda) with hyperammonemia].
    Minauchi K; Fujie T; Matsubara N; Kasahara H; Ogura Y; Tamura M; Yamane Y; Tanaka M; Taneichi K
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):139-41. PubMed ID: 14968586
    [No Abstract]   [Full Text] [Related]  

  • 18. Synchronous detection of multiple myeloma and acute myeloid leukemia: A diagnostic and therapeutic challenge.
    Maral S; Albayrak M; Sahin O; Ozturk HBA; Han U; Falay M
    J Oncol Pharm Pract; 2021 Mar; 27(2):464-469. PubMed ID: 33620259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystalline cast nephropathy in a patient with IgD lambda myeloma.
    Kumakura S; Nakaya I; Sakuma T; Sato H; Soma J
    Clin Exp Nephrol; 2016 Jun; 20(3):491-2. PubMed ID: 26515717
    [No Abstract]   [Full Text] [Related]  

  • 20. Malnutrition-related hyperammonemic encephalopathy presenting with burst suppression: a case report.
    Leidi A; Pisaturo M; Fumeaux T
    J Med Case Rep; 2019 Aug; 13(1):248. PubMed ID: 31399120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.